← Back to Clinical Trials
Recruiting NCT07522307

NCT07522307 Psychological Impact of an 80-km Ultra-Endurance Race

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07522307
Status Recruiting
Phase
Sponsor Centre Hospitalier Régional d'Orléans
Condition Healthy Adult Participants
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2026-03-21
Primary Completion 2026-03-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Completion on a tablet of self-administered questionnaires about their emotions/feelings before, during (kilometers 25, 38, 48, and 56), and at the finish line (80th kilometer)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2026-03-21 with a primary completion date of 2026-03-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Ultra-endurance races (ultra-marathons) take place under extreme environmental conditions, over long distances, involving prolonged physical activity and multiple psychological and physiological challenges. These extreme conditions expose runners to a wide range of emotions-both pleasant and unpleasant-that can influence their performance, fatigue, and perception of exertion. Emotional intelligence and emotional regulation appear to be key determinants of emotional trajectories and performance in these contexts. Previous research shows that high levels of emotional intelligence and adaptive emotional regulation strategies are associated with functional emotional trajectories and better performance, whereas maladaptive strategies are linked to dysfunctional emotional trajectories and reduced performance. Furthermore, defense mechanisms constitute a complementary approach to emotional self-regulation. They can be adaptive or maladaptive and influence how runners cope with emotions and psychological stressors during competition. Longitudinal studies conducted to date have primarily explored post-race emotional trajectories in relation to emotional intelligence, without examining the impact of defense mechanisms on emotional dynamics during the race. Furthermore, few studies have examined the mediating role of emotional intensity between emotional regulation and perceived performance, and even fewer have adopted an approach that integrates physiological indicators such as heart rate or heart rate variability. Thus, this study lies at the intersection of sports psychology, emotion, and physiology, and aims to fill these gaps by exploring: 1. the influence of defense mechanisms on emotional dynamics and physical and mental fatigue during an ultra-endurance race, and 2. the mediating role of emotional intensity on the relationship between emotional regulation and perceived performance. The objective of this study is to examine how certain psychological mechanisms used to cope with difficult situations influence the evolution of emotions experienced by participants during and after an 80-kilometer ultra-endurance race.

Eligibility Criteria

Inclusion Criteria: * Individuals who have agreed to participate in the study * Age ≥ 18 years * Smartwatch capable of measuring heart rate and transmitting this data * Smartwatch capable of measuring heart rate and transmitting this data * Participation in the "Ecotrail de Paris Ile de France 80 kilometers" ultra trail taking place on March 21, 2026. Exclusion Criteria: * Persons under legal guardianship or conservatorship * Persons under judicial protection * Persons deprived of liberty * Persons not enrolled in a social security system * Persons not enrolled in a social security system

Contact & Investigator

Central Contact

Romain JOUFFROY, Pr

✉ romain.jouffroy@chu-orleans.fr

📞 +33238651561

Frequently Asked Questions

Who can join the NCT07522307 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy Adult Participants. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07522307 currently recruiting?

Yes, NCT07522307 is actively recruiting participants. Contact the research team at romain.jouffroy@chu-orleans.fr for enrollment information.

Where is the NCT07522307 trial being conducted?

This trial is being conducted at Orléans, France.

Who is sponsoring the NCT07522307 clinical trial?

NCT07522307 is sponsored by Centre Hospitalier Régional d'Orléans. The trial plans to enroll 80 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology